Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD)

Physiological Reports

Volumn 4, Issue 5, 2016, Pages 1-11

  Winterberg, Pamela D ^a,b   Jiang, Rong ^a,b   Maxwell, Josh T ^a,b,c   Wang, Bo ^a   Wagner, Mary B ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c Emory University   (United States)

Author keywords

Animal model, experimental; Blood pressure; Cardiomyopathy; Chronic kidney failure; Echocardiography; Fibrosis, endomyocardial; Mice; Uremia; Ventricular dysfunction

Indexed keywords

129 MOUSE; ANIMAL; CHRONIC KIDNEY FAILURE; ECHOGRAPHY; HEART VENTRICLE; HEART VENTRICLE REMODELING; MALE; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HEART VENTRICLES; MALE; MICE; MICE, 129 STRAIN; RENAL INSUFFICIENCY, CHRONIC; VENTRICULAR REMODELING;

EID: 84962573323     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12732     Document Type: Article

References (57)

1. Abdurrachim, D., J. Ciapaite, B. Wessels, M. Nabben, J. J. F. P. Luiken, K. Nicolay, et al. 2014. Cardiac diastolic dysfunction in high-fat diet fed mice is associated with lipotoxicity without impairment of cardiac energetics in vivo. Biochim. Biophys. Acta 1842:1525-1537.
2. Aeschbacher, B. C., D. Hutter, J. Fuhrer, P. Weidmann, E. Delacrétaz, and Y. Allemann . 2001. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am. J. Hypertens. 14:106-113.
3. Alhaj, E., N. Alhaj, I. Rahman, T. O. Niazi, R. Berkowitz, and M. Klapholz . 2013. Uremic cardiomyopathy: an underdiagnosed disease. Congest. Heart Fail. 19:E40-E45.
4. Andrews, T. G., M. L. Lindsey, R. A. Lange, and G. J. Aune . 2014. Cardiac assessment in pediatric mice: strain analysis as a diagnostic measurement. Echocardiography 31:375-384.
5. Asp, A. M., C. Wallquist, A. Rickenlund, B. Hylander, S. H. Jacobson, K. Caidahl, et al. 2015. Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects. Clin. Physiol. Funct. Imaging 25:223-230.
6. Bauer, M., S. Cheng, M. Jain, S. Ngoy, C. Theodoropoulos, A. Trujillo, et al. 2011. Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ. Res. 108:908-916.
7. Belke, D. D., and W. H. Dillmann . 2004. Altered cardiac calcium handling in diabetes. Curr. Hypertens. Rep. 6:424-429.
8. Beuckelmann, D. J., M. Näbauer, and E. Erdmann . 1992. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85:1046-1055.
9. 2+]i handling in human ventricular myocytes from patients with terminal heart failure. Am. Heart J. 129:684-689.
10. Bhan, A., A. Sirker, J. Zhang, A. Protti, N. Catibog, W. Driver, et al. 2014. High frequency speckle tracking echocardiography in the assessment of left ventricular function after murine myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 306:H1371-H1383.
11. Bing, O. H., W. W. Brooks, C. H. Conrad, S. Sen, C. L. Perreault, and J. P. Morgan . 1991. Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition to heart failure. Circ. Res. 68:1390-1400.
12. Borbély, A., J. van der Velden, Z. Papp, J. G. F. Bronzwaer, I. Edes, G. J. M. Stienen, et al. 2005. Cardiomyocyte stiffness in diastolic heart failure. Circulation 111:774-781.
13. Chen, T., X. Jin, B. H. Crawford, H. Cheng, T. B. Saafir, M. B. Wagner, et al. 2012. Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase. Free Radic. Biol. Med. 53:208-215.
14. Cheng, J. M., K. M. Akkerhuis, L. C. Battes, L. C. van Vark, H. L. Hillege, W. J. Paulus, et al. 2013. Biomarkers of heart failure with normal ejection fraction: a systematic review. Eur. J. Heart Fail. 15:1350-1362.
15. Chinali, M., M. C. Matteucci, A. Franceschini, A. Doyon, G. Pongiglione, G. Rinelli, et al. 2015. Advanced parameters of cardiac mechanics in children with CKD: the 4C study. Clin. J. Am. Soc. Nephrol. 10:1357-1363.
16. Collier, P., C. J. Watson, V. Voon, D. Phelan, A. Jan, G. Mak, et al. 2011. Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? Eur. J. Heart Fail. 13:1087-1095.
17. Dandel, M., H. Lehmkuhl, C. Knosalla, N. Suramelashvili, and R. Hetzer . 2009. Strain and strain rate imaging by echocardiography - basic concepts and clinical applicability. Curr. Cardiol. Rev. 5:133-148.
18. Davis, J., S. Yasuda, N. J. Palpant, J. Martindale, T. Stevenson, K. Converso, et al. 2012. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy. J. Mol. Cell. Cardiol. 53:446-457.
19. Di Bello, V., E. Talini, G. Dell'Omo, C. Giannini, M. G. Delle Donne, M. L. Canale, et al. 2010. Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study. Am. J. Hypertens. 23:405-412.
20. Drüeke, T. B., F. Locatelli, N. Clyne, K.-U. Eckardt, I. C. Macdougall, D. Tsakiris, et al. 2006. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N. Engl. J. Med. 355:2071-2084.
21. Dupont, S., J. Maizel, R. Mentaverri, J.-M. Chillon, I. Six, P. Giummelly, et al. 2012. The onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension. Am. J. Physiol. Heart Circ. Physiol. 302:H1524-H1532.
22. Edwards, N. C., C. J. Ferro, J. N. Townend, and R. P. Steeds . 2008a. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart 94:1038-1043.
23. Edwards, N. C., A. Hirth, C. J. Ferro, J. N. Townend, and R. P. Steeds . 2008b. Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy? J. Am. Soc. Echocardiogr. 21:1293-1298.
24. Eknoyan, G., G. J. Beck, A. K. Cheung, J. T. Daugirdas, T. Greene, J. W. Kusek, et al. 2002. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347:2010-2019.
25. Groothoff, J. W., M. P. Gruppen, M. Offringa, J. Hutten, M. R. Lilien, N. J. Van De Kar, et al. 2002. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int. 61:621-629.
26. Hallan, S. I., K. Matsushita, Y. Sang, B. K. Mahmoodi, C. Black, A. Ishani, et al. 2012. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 308:2349-2360.
27. Haugaa, K. H., B. L. Grenne, C. H. Eek, M. Ersbøll, N. Valeur, J. H. Svendsen, et al. 2013. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. JACC Cardiovasc. Imaging 6:841-850.
28. Hayashi, S. Y., M. Rohani, B. Lindholm, L.-A. Brodin, B. Lind, P. Barany, et al. 2006. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol. Dial. Transplant. 21:125-132.
29. Jamison, R. L., P. Hartigan, J. S. Kaufman, D. S. Goldfarb, S. R. Warren, P. D. Guarino, et al.; Veterans Affairs Site Investigators. 2007. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease. JAMA 298:1163.
30. Kasner, M., R. Gaub, D. Sinning, D. Westermann, P. Steendijk, W. Hoffmann, et al. 2010. Global strain rate imaging for the estimation of diastolic function in HFNEF compared with pressure-volume loop analysis. Eur. J. Echocardiogr. 11:743-751.
31. Kennedy, D., E. Omran, S. M. Periyasamy, J. Nadoor, A. Priyadarshi, J. C. Willey, et al. 2003. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J. Am. Soc. Nephrol. 14:90-97.
32. Kennedy, D. J., J. Elkareh, A. Shidyak, A. P. Shapiro, S. Smaili, K. Mutgi, et al. 2008. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am. J. Physiol. Renal. Physiol. 294:F450-F454.
33. Koshizuka, R., T. Ishizu, Y. Kameda, R. Kawamura, Y. Seo, and K. Aonuma . 2013. Longitudinal strain impairment as a marker of the progression of heart failure with preserved ejection fraction in a rat model. J. Am. Soc. Echocardiogr. 26:316-323.
34. Krüger, C., E. Erdmann, M. Näbauer, and D. J. Beuckelmann . 1994. Intracellular calcium handling in isolated ventricular myocytes from cardiomyopathic hamsters (strain BIO 14.6) with congestive heart failure. Cell Calcium 16:500-508.
35. Lacombe, V. A., S. Viatchenko-Karpinski, D. Terentyev, A. Sridhar, S. Emani, J. D. Bonagura, et al. 2007. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R1787-R1797.
36. Leelahavanichkul, A., Q. Yan, X. Hu, C. Eisner, Y. Huang, R. Chen, et al. 2010. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 78:1136-1153.
37. Lin, C.-Y., Y.-J. Hsu, S.-C. Hsu, Y. Chen, H.-S. Lee, S.-H. Lin, et al. 2015. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia. J. Mol. Cell. Cardiol. 85:249-261.
38. Locatelli, F., P. Aljama, B. Canaud, A. Covic, A. De Francisco, I. C. Macdougall, et al. 2010. Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol. Dial. Transplant. 25:2846-2850.
39. Ma, L.-J., and A. B. Fogo . 2003. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int. 64:350-355.
40. Matteucci, M. C., M. Chinali, G. Rinelli, E. Wühl, A. Zurowska, M. Charbit, et al. 2013. Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. Clin. J. Am. Soc. Nephrol. 8:203-210.
41. McMahon, A. C., S. E. Greenwald, S. M. Dodd, M. J. Hurst, and A. E. G. Raine . 2002. Prolonged calcium transients and myocardial remodelling in early experimental uraemia. Nephrol. Dial. Transplant. 17:759-764.
42. Mitsnefes, M. M., T. R. Kimball, W. L. Border, S. A. Witt, B. J. Glascock, P. R. Khoury, et al. 2004. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 65:1461-1466.
43. Mitsnefes, M. M., T. R. Kimball, J. Kartal, S. A. Witt, B. J. Glascock, P. R. Khoury, et al. 2006. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J. Pediatr. 149:671-675.
44. Nasir, K., B. D. Rosen, H. J. Kramer, T. Edvardsen, D. A. Bluemke, K. Liu, et al. 2007. Regional left ventricular function in individuals with mild to moderate renal insufficiency: the Multi-Ethnic Study of Atherosclerosis. Am. Heart J. 153:545-551.
45. Palmer, S. C., S. D. Navaneethan, J. C. Craig, D. W. Johnson, V. Perkovic, S. U. Nigwekar, et al. 2013. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst. Rev. 9:CD004289.
46. Parekh, R. S., C. E. Carroll, R. A. Wolfe, and F. K. Port . 2002. Cardiovascular mortality in children and young adults with end-stage kidney disease. J. Pediatr. 141:191-197.
47. Park, M., C. Hsu, Y. Li, R. K. Mishra, M. Keane, S. E. Rosas, et al. 2012. Associations between kidney function and subclinical cardiac abnormalities in CKD. J. Am. Soc. Nephrol. 23:1725-1734.
48. Rakhit, D. J., X. H. Zhang, R. Leano, K. A. Armstrong, N. M. Isbel, and T. H. Marwick . 2007. Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. Am. Heart J. 153:656-664.
49. Roes, S. D., S. A. Mollema, H. J. Lamb, E. E. van der Wall, A. de Roos, and J. J. Bax . 2009. Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging. Am. J. Cardiol. 104:312-317.
50. Scavarda, V. T., A. C. Pinheiro, S. D. Costa, de Andrade Z. M., J. T. Carvalhaes, O. Campos, et al. 2014. Children with chronic renal disease undergoing dialysis or conservative treatment-differences in structural and functional echocardiographic parameters. Echocardiography 31:1131-1137.
51. Schneider, C. A., W. S. Rasband, and K. W. Eliceiri . 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9:671-675.
52. Siedlecki, A. M., X. Jin, and A. J. Muslin . 2009. Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney Int. 75:800-808.
53. Stenvinkel, P., J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimbürger, and Z. Massy . 2008. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin. J. Am. Soc. Nephrol. 3:505-521.
54. Tee, M., J. A. Noble, and D. A. Bluemke . 2013. Imaging techniques for cardiac strain and deformation: comparison of echocardiography, cardiac magnetic resonance and cardiac computed tomography. Expert Rev. Cardiovasc. Ther. 11:221-231.
55. Tonelli, M., N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, et al. 2006. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17:2034-2047.
56. 2+ homeostasis in rabbits with pacing-induced heart failure. Am. J. Physiol. 275:H1441-H1448.
57. Zannad, F., M. Kessler, P. Lehert, J. P. Grünfeld, C. Thuilliez, A. Leizorovicz, et al. 2006. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 70:1318-1324.